Publication: 2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies
Program
Institution Authors
Authors
Qayed W. S.
Hassan M. A.
Şenol H.
Taslimi P.
Aboul-Fadl T.
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source:
Keywords:
Keywords
Eczacılık, Meslek Bilimleri, Farmasötik Kimya, Sağlık Bilimleri, Pharmacology and Therapeutics, Professional Sciences, Pharmaceutical Chemistry, Health Sciences, Klinik Tıp (Med), Yaşam Bilimleri (Life), Farmakoloji ve Toksikoloji, Farmakoloji ve Eczacılık, Clinical Medicine (Med), Life Sciences (Life), Pharmacology & Toxicology, Pharmacology & Pharmacy, Farmakoloji, Farmakoloji, Toksikoloji ve Eczacılık (çeşitli), Genel Farmakoloji, Toksikoloji ve Eczacılık, Farmakoloji (tıbbi), İlaç Rehberleri, Yaşam Bilimleri, Pharmacy, Pharmacology, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), General Pharmacology, Toxicology and Pharmaceutics, Pharmacology (medical), Drug Guides, Life Sciences
Citation
Qayed W. S., Hassan M. A., Şenol H., Taslimi P., Aboul-Fadl T., "2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies", RSC MEDICINAL CHEMISTRY, cilt.16, sa.11, ss.1-25, 2025